Caplin Point Laboratories Limited

CAPLIPOINT.NS·NSE·Healthcare
Compare
2,200.10−21.50 (−0.97%)today
As of Oct 22, 9:54 AM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,221.60
Open2,197.60
Day range2,176.202,222.60
52-week range1,500.302,990.00
Off day high−1.01%
Off 52-week high−26.42%
Volume15.59K
Avg. volume (3M)185.07K
Market cap167.23B
EPS (TTM)88.74
Forward P/E19.87
P/E ratio (TTM)24.79
Dividend yield0.36% (8.00)
Beta (5Y)0.42
Shares outstanding76.01M
Short interest—
Earnings dateAug 5, 2025 (est.)
Analyst target2,765.00
Profit margin29.09%

Against its peers

Compare in full ›
CAPLIPOINT.NS GRANULES.BO LUPIN.NS IPCALAB.BO JUBLPHARMA.BO PPLPHARMA.NS
Market cap 167.23B 196.84B 881.20B 492.96B 145.40B 257.54B
P/E (TTM) 24.8 36.1 16.0 39.7 41.1 —
Forward P/E 19.9 27.0 19.0 27.6 18.2 47.9
Price/book 4.8 4.9 3.9 6.1 2.0 3.2
Dividend yield 0.36% 0.26% 0.92% 0.31% 0.54% —
1-year change +11.66% +0.63% +1.12% +42.49% −16.85% −3.09%
Today −0.97% +1.00% −1.88% +1.37% −1.30% +1.66%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.